|
WDR45L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.202100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.724200E-01 |
| Normal-vs-Stage2 |
1.443550E-02 |
| Normal-vs-Stage3 |
3.65580000000199E-05 |
| Normal-vs-Stage4 |
2.22639999999386E-05 |
| Stage1-vs-Stage2 |
2.012400E-02 |
| Stage1-vs-Stage3 |
1.28050000003377E-06 |
| Stage1-vs-Stage4 |
2.12950000000323E-06 |
| Stage2-vs-Stage3 |
2.635800E-01 |
| Stage2-vs-Stage4 |
1.511640E-01 |
| Stage3-vs-Stage4 |
5.582400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.603660E-03 |
| Normal-vs-AfricanAmerican |
8.763000E-01 |
| Normal-vs-Asian |
6.484000E-01 |
| Caucasian-vs-AfricanAmerican |
6.994300E-02 |
| Caucasian-vs-Asian |
1.777020E-01 |
| AfricanAmerican-vs-Asian |
7.101000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.221500E-04 |
| Normal-vs-Female |
4.680400E-01 |
| Male-vs-Female |
4.612000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.798500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.320410E-02 |
| Normal-vs-Age(61-80Yrs) |
1.969570E-02 |
| Normal-vs-Age(81-100Yrs) |
3.755600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.034300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.974000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.494040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.361600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.258200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.916800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.478320E-02 |
| Normal-vs-Grade 2 |
5.016200E-01 |
| Normal-vs-Grade 3 |
3.996000E-04 |
| Normal-vs-Grade 4 |
3.28050000497626E-08 |
| Grade 1-vs-Grade 2 |
1.421570E-02 |
| Grade 1-vs-Grade 3 |
2.389700E-04 |
| Grade 1-vs-Grade 4 |
2.53279999973266E-07 |
| Grade 2-vs-Grade 3 |
3.248000E-04 |
| Grade 2-vs-Grade 4 |
4.49200000529615E-08 |
| Grade 3-vs-Grade 4 |
6.358300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.514000E-01 |
| Normal-vs-ccB subtype |
2.22249999999313E-05 |
| ccA subtype-vs-ccB subtype |
6.92079999975448E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.799000E-03 |
| Normal-vs-N1 |
7.618200E-03 |
| N0-vs-N1 |
2.426200E-01 |
|
|
